This study is testing whether a standard stem cell transplant for blood cancers can be done safely without one of the immune-suppressing drugs (mycophenolate mofetil or MMF). The goal is to see if removing this drug reduces side effects while still controlling the cancer. The tri…
Phase: PHASE2 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC